At a Glance
RA Capital Management is a leading crossover healthcare investment firm founded in 2001 by Dr. Peter Kolchinsky, a Harvard-trained scientist and former McKinsey consultant. The firm specializes in investing across both public and private biotech and pharmaceutical companies, with a particular focus on companies developing transformative therapeutics. RA Capital's unique approach combines deep scientific expertise with investment acumen, allowing them to evaluate complex drug development programs and identify promising therapeutic opportunities.
The firm gained significant prominence through early investments in companies like Moderna, where they were longtime supporters before the company's COVID-19 vaccine success, and Beam Therapeutics, a leader in base editing technology. RA Capital's portfolio spans multiple therapeutic areas including oncology, rare diseases, and infectious diseases, with notable investments in Dicerna Pharmaceuticals, Prothena, and Sangamo Therapeutics.
What sets RA Capital apart is their ability to provide both capital and strategic guidance throughout the entire lifecycle of biotech companies, from early-stage private ventures to established public companies. Their team includes scientists, physicians, and experienced investors who can navigate the complex regulatory and clinical development landscape. The firm's Boston headquarters positions them at the heart of the biotech ecosystem, enabling close collaboration with academic institutions and industry partners.
“Science-driven investing in therapeutics companies developing transformative medicines.”
RA Capital Management primarily invests at the Series A, Series B+ stages. This means they focus on companies that are scaling their go-to-market after proving product-market fit.
RA Capital Management is headquartered in Boston, MA. Many of their portfolio companies are also based in this region, though they invest across geographies.
RA Capital Management focuses on investments in Biotech, Digital Health. Their portfolio reflects deep expertise and networks within these sectors.
RA Capital Management's typical investment check size ranges from $5M to $100M. Actual amounts may vary based on the stage, sector, and specific opportunity.
RA Capital Management manages approximately $10B+ in assets under management (AUM) across their funds.
